Authors:
KARALI N
GURSOY A
TERZIOGLU N
OZKIRIMLI S
OZER H
EKINCI AC
Citation: N. Karali et al., SYNTHESIS AND PRELIMINARY CNS DEPRESSANT ACTIVITY EVALUATION OF NEW HIAZOLIDINON-2-YLIDENE)HYDRAZONO]-1H-2-INDOLINONES AND ,5-IMIDAZOLIDINE-DION-1-YL)IMINO]-1H-2-INDOLINONES, Archiv der pharmazie, 331(7-8), 1998, pp. 254-258
Citation: H. Ozer et al., RECOMBINANT INTERFERON-ALPHA THERAPY IN PATIENTS WITH FOLLICULAR LYMPHOMA (VOL 82, PG 1821, 1998), Cancer, 83(3), 1998, pp. 593-593
Citation: Ml. Ovecoglu et al., CHARACTERIZATION AND CRYSTALLIZATION KINETICS OF A DIOPSIDE-BASED GLASS-CERAMIC DEVELOPED FROM GLASS INDUSTRY RAW-MATERIALS, Journal of the European Ceramic Society, 17(7), 1997, pp. 957-962
Authors:
OZER H
MILLER LL
SCHIFFER CA
WINN RJ
SOMERFIELD MR
SMITH TJ
Citation: H. Ozer et al., 1997 UPDATE OF RECOMMENDATIONS FOR THE USE OF HEMATOPOIETIC COLONY-STIMULATING FACTORS - EVIDENCE-BASED, CLINICAL-PRACTICE GUIDELINES, Journal of clinical oncology, 15(10), 1997, pp. 3288-3288
Authors:
LUIKART SD
HERNDON JE
HOLLIS DR
MACDONALD M
MAURER LH
CRAWFORD J
CLAMON GH
WRIGHT J
PERRY MC
OZER H
GREEN MR
Citation: Sd. Luikart et al., PHASE-I TRIAL OF ETOPOSIDE, CARBOPLATIN, AND GM-CSF IN EXTENSIVE SMALL-CELL LUNG-CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY (CALGB-8832), American journal of clinical oncology, 20(1), 1997, pp. 24-30
Citation: Ce. Desch et H. Ozer, NEUTROPENIA AND NEOPLASIA - AN OVERVIEW OF THE PHARMACOECONOMICS OF SARGRAMOSTIM IN CANCER-THERAPY, Clinical therapeutics, 19(4), 1997, pp. 847-865
Authors:
FANUCCHI M
GLASPY J
CRAWFORD J
GARST J
FIGLIN R
SHERIDAN W
MENCHACA D
TOMITA D
OZER H
HARKER L
Citation: M. Fanucchi et al., EFFECTS OF POLYETHYLENE GLYCOL-CONJUGATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR ON PLATELET COUNTS AFTER CHEMOTHERAPY FOR LUNG-CANCER, The New England journal of medicine, 336(6), 1997, pp. 404-409
Citation: S. Kaur et al., MK-801 REVERSES HALOPERIDOL-INDUCED CATALEPSY FROM BOTH STRIATAL AND EXTRASTRIATAL SITES IN THE RAT-BRAIN, European journal of pharmacology, 332(2), 1997, pp. 153-160
Citation: H. Ozer et M. Starr, DIFFERENTIAL INTERACTION OF DIZOCILPINE WITH DOPAMINE D1-INDUCED AND D2-INDUCED CATALEPSY, British Journal of Pharmacology, 120, 1997, pp. 248-248
Citation: H. Ozer et al., DOPAMINE D-1-DEPENDENT AND D-2-DEPENDENT CATALEPSY IN THE RAT REQUIRES FUNCTIONAL NMDA RECEPTORS IN THE CORPUS STRIATUM, NUCLEUS-ACCUMBENS AND SUBSTANTIA-NIGRA PARS RETICULATA, Brain research, 777(1-2), 1997, pp. 51-59
Citation: H. Ozer et al., INTEGRATED ANALYSIS OF THE SAFETY AND EFFICACY OF CONCURRENT THERAPY WITH RIFN-ALPHA AND CHEMOTHERAPY IN FOLLICULAR NHL, Blood, 90(10), 1997, pp. 3933-3933
Authors:
WIERNIK P
OZER H
OKEN M
GILES F
SOLALCELIGNY P
COIFFIER B
Citation: P. Wiernik et al., PROGNOSTIC FACTORS IN PATIENT SELECTION FOR TREATMENT WITH INTERFERON-ALFA IN LOW-GRADE FOLLICULAR LYMPHOMA, Blood, 90(10), 1997, pp. 1503-1503
Authors:
ELMAS N
YORULMAZ I
ORAN I
OYAR O
OZUTEMIZ O
OZER H
Citation: N. Elmas et al., A NEW CRITERION IN DIFFERENTIATION OF PANCREATITIS AND PANCREATIC-CARCINOMA - ARTERY-TO-VEIN RATIO USING THE SUPERIOR MESENTERIC VESSELS, Abdominal imaging, 21(4), 1996, pp. 331-333
Authors:
CRAWFORD J
OROURKE M
SCHILLER JH
SPIRIDONITIS CH
YANOVICH S
OZER H
LANGLEBEN A
HUTCHINS L
KOLETSKY A
CLAMON G
BURMAN S
WHITE R
HOHNEKER J
Citation: J. Crawford et al., RANDOMIZED TRIAL OF VINORELBINE COMPARED WITH FLUOROURACIL PLUS LEUCOVORIN IN PATIENTS WITH STAGE-IV NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 14(10), 1996, pp. 2774-2784
Citation: N. Ulusoy et al., SYNTHESIS AND ANTICONVULSANT ACTIVITY OF SOME NEW ARYLIDENEHYDRAZIDESAND 4-THIAZOLIDINONES, Monatshefte fuer Chemie, 127(11), 1996, pp. 1197-1202
Authors:
KATTAN MW
INOUE Y
GILES FJ
TALPAZ M
OZER H
GUILHOT F
ZUFFA E
HUBER SL
BECK JR
Citation: Mw. Kattan et al., COST-EFFECTIVENESS OF INTERFERON-ALPHA AND CONVENTIONAL CHEMOTHERAPY IN CHRONIC MYELOGENOUS LEUKEMIA, Annals of internal medicine, 125(7), 1996, pp. 541
Authors:
RAI KR
DAVEY F
PETERSON B
SCHIFFER C
SILVER RT
OZER H
GOLOMB H
BLOOMFIELD CD
Citation: Kr. Rai et al., RECOMBINANT INTERFERON-ALPHA-2B IN THERAPY OF PREVIOUSLY UNTREATED HAIRY-CELL LEUKEMIA - LONG-TERM FOLLOW-UP RESULTS OF STUDY BY CANCER ANDLEUKEMIA GROUP-B, Leukemia, 9(7), 1995, pp. 1116-1120
Authors:
KALUZNY AD
WARNECKE R
LACEY LM
JOHNSON T
GILLINGS D
OZER H
Citation: Ad. Kaluzny et al., USING A COMMUNITY CLINICAL-TRIALS NETWORK FOR TREATMENT, PREVENTION, AND CONTROL RESEARCH - ASSURING ACCESS TO STATE-OF-THE-ART CANCER CARE, Cancer investigation, 13(5), 1995, pp. 517-525
Authors:
BANGA S
KIM S
HUBBARD K
JHA K
KRAEMER P
OZER H
Citation: S. Banga et al., MAPPING OF SEN6, A GENE INVOLVED IN IMMORTALIZATION OF HUMAN FIBROBLASTS, TO CHROMOSOMAL REGION 6Q26-27, American journal of human genetics, 57(4), 1995, pp. 309-309
Authors:
CRAWFORD J
OZER H
STOLLER R
JOHNSON D
LYMAN G
TABBARA I
KRIS M
GROUS J
PICOZZI V
RAUSCH G
SMITH R
GRADISHAR W
YAHANDA A
VINCENT M
STEWART M
GLASPY J
Citation: J. Crawford et al., REDUCTION BY GRANULOCYTE-COLONY-STIMULATING FACTOR OF FEVER AND NEUTROPENIA INDUCED BY CHEMOTHERAPY IN PATIENTS WITH SMALL-CELL LUNG-CANCER, Clinical infectious diseases, 18, 1994, pp. 190000189-190000196
Authors:
JOHNSON TP
FORD L
WARNECKE RB
NAYFIELD SG
KALUZNY A
CUTTER G
GILLINGS D
SONDIK E
OZER H
Citation: Tp. Johnson et al., EFFECT OF A NATIONAL-CANCER-INSTITUTE CLINICAL-ALERT ON BREAST-CANCERPRACTICE PATTERNS, Journal of clinical oncology, 12(9), 1994, pp. 1783-1788
Authors:
WU Y
HICKEY R
LAWLOR K
WILLS P
YU F
OZER H
STARR R
QUAN JY
LEE M
MALKAS L
Citation: Y. Wu et al., A 17S MULTIPROTEIN FORM OF MURINE CELL-DNA POLYMERASE MEDIATES POLYOMAVIRUS DNA-REPLICATION IN-VITRO, Journal of cellular biochemistry, 54(1), 1994, pp. 32-46